Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

36.30
Delayed Data
As of 4:02pm ET
 +0.39 / +1.09%
Today’s Change
34.57
Today|||52-Week Range
66.55
-44.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues4.9B4.8B5.1B5.7B
 
 
 
 
 
Cost of Goods Sold1.7B1.7B1.9B2.2B
 
 
 
 
 
Depreciation And Amortization335.9M305.3M314.0M587.3M
 
 
 
 
 
 
Operating ExpensesGross Income2.9B2.8B2.9B2.9B
 
 
 
 
 
General Expenses1.7B1.5B1.7B1.9B
 
 
 
 
 
Research And Development447.2M389.3M379.9M674.9M
 
 
 
 
 
Total Operating Expenses3.7B3.6B3.8B4.8B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.2B1.3B1.3B903.9M
 
 
 
 
 
Extraordinary Credit--44.0M4.1M705.4M
 
 
 
 
Extraordinary Charge-298.8M-120.1M-964.4M-850.0M
 
 
 
 
 
Interest Expense On Debt47.1M71.1M--108.9M
 
 
 
 
Equity In Earnings-114.3M-6.0M15.2M2.0M
 
 
 
 
 
Other Expenses12.0M-245.2M-160.1M-24.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income863.2M867.8M259.3M626.0M
 
 
 
 
 
Income Taxes-249.6M-228.2M-29.4M-210.7M
 
 
 
 
 
Minority Interest-2.0M-3.0M-12.2M-2.0M
 
 
 
 
 
Preferred Dividend-15.0M-66.1M-66.9M-65.1M
 
 
 
 
 
Net Income501.3M636.6M257.3M419.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS866.0M913.0M914.0M979.0M
 
 
 
 
 
Shares To Calculate EPS Diluted875.0M920.0M920.0M984.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.56$0.62$0.21$0.36
 
 
 
 
 
EPS Diluted$0.55$0.62$0.20$0.36